Laurence Albiges M.D., PhD medical oncologist in the Genitourinary group of the Department of Cancer Medicine at the Institute Gustave Roussy Discusses Is HIF Inhibition The Right Target In RCC. At The Fourteenth European International Kidney Cancer Symposium on Mar 29, 2019.
